Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aptinyx Inc (NQ: APTX )

3.200 USD UNCHANGED
Official Closing Price Updated: 6:42 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 602,600
Open 3.220
Bid (Size) 3.200 (1)
Ask (Size) 3.300 (3)
Prev. Close 3.200
Today's Range 2.850 - 3.270
52wk Range 1.600 - 6.470
Shares Outstanding 32,536,225
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aptinyx to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, March 24, 2021
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that the company... 
From Business Wire News Releases
Aptinyx to Participate in Upcoming Investor Conferences
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that company... 
From Business Wire News Releases

Performance

YTD
-6.98%
-6.98%
1 Month
-15.57%
-15.57%
3 Month
-15.12%
-15.12%
6 Month
-2.14%
-2.14%
1 Year
+1.27%
+1.27%

More News

Read More
Aptinyx to Participate at 10th Annual SVB Leerink Global Healthcare Conference
From Business Wire News Releases
Aptinyx Announces Publication of Review Article Highlighting Preclinical Data in Medicine in Drug Discovery Demonstrating the Potential of NYX-2925 to Treat Chronic, Centralized Pain Conditions
From Business Wire News Releases
Aptinyx to Participate in H.C. Wainwright BioConnect 2021 Conference
From Business Wire News Releases
Aptinyx Announces Recommencement of Phase 2 Study of NYX-2925 in Patients With Painful Diabetic Peripheral Neuropathy
From Business Wire News Releases
Aptinyx to Present at the 39th Annual J.P. Morgan Healthcare Conference
From Business Wire News Releases
Aptinyx Appoints Andy Kidd, M.D., President and Chief Operating Officer
From Business Wire News Releases
Aptinyx Reports Third Quarter 2020 Financial Results and Recent Highlights
From Business Wire News Releases
Return On Capital Employed Overview: Aptinyx
Tags News APTX BZI/ROCE
From Benzinga
Aptinyx to Participate in Upcoming Virtual Investor Conferences
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.